RESUMO
Dual pathology is often found in addiction and mental health centers. Although there are integrated services for these patients, most countries have developed joint action protocols between addiction and mental health centers. The objective is to analyze the progress of patients diagnosed with dual pathology, comparing the therapeutic outcomes of those who exclusively attend either addiction or mental health centers with those patients who follow a program in which the two services are coordinated. It is hypothesized that patients assisted in coordinate manner will present a better evolution on psychopathological symptomatology, drug use and functional impairment.
Assuntos
Transtornos Mentais/terapia , Serviços de Saúde Mental/organização & administração , Centros de Tratamento de Abuso de Substâncias/organização & administração , Transtornos Relacionados ao Uso de Substâncias/terapia , Diagnóstico Duplo (Psiquiatria) , Feminino , Humanos , Estudos Longitudinais , Masculino , Transtornos Mentais/complicações , Transtornos Mentais/psicologia , Pacientes Desistentes do Tratamento/estatística & dados numéricos , Recidiva , Índice de Gravidade de Doença , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/psicologiaRESUMO
IFN-γ release assays (IGRAs) are better indicators of Mycobacterium tuberculosis infection than the tuberculin skin test (TST) in Bacillus Calmette-Guérin (BCG)-vaccinated populations. However, IGRAs do not discriminate active and latent infections (LTBI) and no gold standard for LTBI diagnosis is available. Thus, since improved tests to diagnose M. tuberculosis infection are required, we assessed the efficacy of several M. tuberculosis latency antigens. BCG-vaccinated healthy donors (HD) and tuberculosis (TB) patients were recruited. QuantiFERON-TB Gold In-Tube, TST and clinical data were used to differentiate LTBI. IFN-γ production against CFP-10, ESAT-6, Rv2624c, Rv2626c and Rv2628 antigens was tested in peripheral blood mononuclear cells. LTBI subjects secreted significantly higher IFN-γ levels against Rv2626c than HD. Additionally, Rv2626c peptide pools to which only LTBI responded were identified, and their cumulative IFN-γ response improved LTBI discrimination. Interestingly, whole blood stimulation with Rv2626c allowed the discrimination between active and latent infections, since TB patients did not secrete IFN-γ against Rv2626c, in contrast to CFP-10 + ESAT-6 stimulation that induced IFN-γ response from both LTBI and TB patients. ROC analysis confirmed that Rv2626c discriminated LTBI from HD and TB patients. Therefore, since only LTBI recognizes specific epitopes from Rv2626c, this antigen could improve LTBI diagnosis, even in BCG-vaccinated people.
Assuntos
Antígenos de Bactérias/imunologia , Interferon gama/imunologia , Leucócitos Mononucleares/imunologia , Mycobacterium bovis/imunologia , Mycobacterium tuberculosis/imunologia , Vacinas contra a Tuberculose/administração & dosagem , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Vacinas contra a Tuberculose/imunologiaRESUMO
Protective immunity against Mycobacterium tuberculosis (Mtb) requires IFNG. Besides, IFNG-mediated induction of autophagy suppresses survival of virulent Mtb in macrophage cell lines. We investigated the contribution of autophagy to the defense against Mtb antigen (Mtb-Ag) in cells from tuberculosis patients and healthy donors (HD). Patients were classified as high responders (HR) if their T cells produced significant IFNG against Mtb-Ag; and low responders (LR) when patients showed weak or no T cell responses to Mtb-Ag. The highest autophagy levels were detected in HD cells whereas the lowest quantities were observed in LR patients. Interestingly, upon Mtb-Ag stimulation, we detected a positive correlation between IFNG and MAP1LC3B-II/LC3-II levels. Actually, blockage of Mtb-Ag-induced IFNG markedly reduced autophagy in HR patients whereas addition of limited amounts of IFNG significantly increased autophagy in LR patients. Therefore, autophagy collaborates with human immune responses against Mtb in close association with specific IFNG secreted against the pathogen.
Assuntos
Antígenos de Bactérias/imunologia , Autofagia/efeitos dos fármacos , Interferon gama/metabolismo , Interferon gama/farmacologia , Mycobacterium tuberculosis/imunologia , Tuberculose/tratamento farmacológico , Autofagia/imunologia , Feminino , Humanos , Macrófagos/imunologia , Macrófagos/microbiologia , Masculino , Células Th1/efeitos dos fármacos , Células Th1/imunologia , Tuberculose/imunologiaRESUMO
Una bacterióloga sufrió un accidente por punción con una aguja con jeringa que contenía una cepa de Mycobacterium tuberculosis en un dedo de la mano. La zona de la punción se inflamó y la expresión del dedo 15 días después del accidente arrojó una gota de pus que puesta al microscopio permitió observar 3 bacilos ácido-alcohol resistentes con la técnica de Ziehl-Neelsen. Se diagnosticó tuberculosis por inoculación accidental y fue tratada como tal. Se discuten las características de este caso encuadrado como tuberculosis cutánea, cuando se produce como infección exógena por inoculación directa.
A bacteriologist suffered a puncture accident while manipulating a Mycobacterium tuberculosis strain, affecting a finger. The involved area swelled and a drop of pus came out after pressure on the finger 15 days afterwards. This was stained by Ziehl-Neelsen technique, and three acid-fast bacilli were observed. Tuberculosis was diagnosed, and proper treatment was started. We discuss the case, classified as cutaneous tuberculosis produced by exogenous infection through accidental direct inoculation.
Assuntos
Humanos , Adulto , Feminino , Infecção Laboratorial/etiologia , Tuberculose Cutânea/etiologia , Infecção Laboratorial/tratamento farmacológico , Agulhas , Punções , Teste Tuberculínico , Tuberculose Cutânea/tratamento farmacológicoRESUMO
Pulmonary disease due to nontuberculous myco bacteria is a well known clinical entity, being Mycobacterium avium complex the pathogen most frequently involved. The Lady Windermere syndrome is a variation of this disease, as interesting as it is little known.
Assuntos
Complexo Mycobacterium avium/isolamento & purificação , Infecção por Mycobacterium avium-intracellulare/diagnóstico , Infecções Respiratórias/diagnóstico , Idoso , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Infecções Respiratórias/microbiologia , Síndrome , Tomografia Computadorizada por Raios XRESUMO
La enfermedad pulmonar por micobacterias ambientales es una entidad clínica conocida, siendo el Mycobacterium avium complex el patógeno involucrado con más frecuencia. El síndrome de Lady Windermere es una variedad de esta enfermedad, tan interesante como poco conocida.
Pulmonary disease due to nontuberculous myco bacteria is a well known clinical entity, being Mycobacterium avium complex the pathogen most frequently involved. The Lady Windermere syndrome is a variation of this disease, as interesting as it is little known.
Assuntos
Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Complexo Mycobacterium avium/isolamento & purificação , Infecção por Mycobacterium avium-intracellulare/diagnóstico , Infecções Respiratórias/diagnóstico , Diagnóstico Diferencial , Infecções Respiratórias/microbiologia , Síndrome , Tomografia Computadorizada por Raios XRESUMO
Pulmonary disease, due to Mycobacteria other than tuberculosis, is mainly suspected in HIV + patients, or underlying other diseases. In our country, there is no updated information on the prevalence of this pulmonary disease, its treatment and evolution in immucocompetent patients. We present 10 cases of pulmonary disease due to Mycobacteria other than tuberculosis in non HIV patients: clinical-bacteriological diagnosis, treatment and evolution.
Assuntos
Soronegatividade para HIV , Complexo Mycobacterium avium/isolamento & purificação , Infecção por Mycobacterium avium-intracellulare/epidemiologia , Pneumonia Bacteriana/microbiologia , Adulto , Idoso , Argentina/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecção por Mycobacterium avium-intracellulare/complicações , Infecção por Mycobacterium avium-intracellulare/imunologia , Pneumonia Bacteriana/epidemiologia , Pneumonia Bacteriana/terapiaRESUMO
La enfermedad provocada por micobacterias ambientales es sospechada fundamentalmente en pacientesHIV positivos o con otras enfermedades de base. En nuestro país no hay información actualizadaacerca de la prevalencia, tratamiento y evolución de esta enfermedad en pacientes inmunocompetentes.Presentamos 10 casos de enfermedad pulmonar por micobacterias ambientales en pacientes inmunocompetentes:diagnóstico clínico-bacteriológico, tratamiento y evolución.
Pulmonary disease,due to Mycobacteria other than tuberculosis, is mainly suspected in HIV + patients, or underlyingother diseases. In our country, there is no updated information on the prevalence of this pulmonarydisease, its treatment and evolution in immucocompetent patients. We present 10 cases of pulmonary diseasedue to Mycobacteria other than tuberculosis in non HIV patients: clinical-bacteriological diagnosis, treatment andevolution.